C. Schmidt

发表

Rapidly progressive Alzheimer's disease: a multicenter update.

J. Laplanche, P. Martínez-Martín, H. Kretzschmar, 2012, Journal of Alzheimer's disease : JAD.

Pulvinar Sign in Wernicke's Encephalopathy

I. Zerr, D. Summers, C. Schmidt, 2010, CNS Spectrums.

I. Zerr, C. Korth, M. Wolff, 2011, Archives of neurology.

Total and Phosphorylated Cerebrospinal Fluid Tau in the Differential Diagnosis of Sporadic Creutzfeldt-Jakob Disease and Rapidly Progressive Alzheimer’s Disease

J. Wiltfang, I. Zerr, P. Hermann, 2022, Viruses.

Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Show Different but Partially Overlapping Profile Compared to Vascular Dementia

I. Zerr, F. Llorens, A. Fischer, 2017, Front. Aging Neurosci..

Evaluation of α-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases

B. Mollenhauer, P. Liberski, D. Varges, 2017, Alzheimer's & Dementia.

Comparative analysis of cerebrospinal fluid biomarkers in the differential diagnosis of neurodegenerative dementia

A. Karch, D. Varges, I. Zerr, 2016, Alzheimer's & Dementia.

Enhanced Chemokine Receptor Expression on Leukocytes of Patients with Alzheimer's Disease

I. Zerr, G. Pawelec, A. Larbi, 2013, PloS one.

Cerebrospinal Fluid Mitochondrial DNA in Rapid and Slow Progressive Forms of Alzheimer’s Disease

I. Zerr, F. Llorens, D. Sepulveda-Falla, 2020, International journal of molecular sciences.

Clinical Features of Rapidly Progressive Alzheimer’s Disease

H. Kretzschmar, B. Meissner, I. Zerr, 2010, Dementia and Geriatric Cognitive Disorders.

CSF prion protein concentration and cognition in patients with Alzheimer disease

I. Zerr, C. Schmidt, Svetlana Artjomova, 2013, Prion.

Immune responses in rapidly progressive dementia: a comparative study of neuroinflammatory markers in Creutzfeldt-Jakob disease, Alzheimer’s disease and multiple sclerosis

I. Zerr, M. Schmitz, K. Stoeck, 2014, Journal of Neuroinflammation.

Stratification by Genetic and Demographic Characteristics Improves Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers in Rapidly Progressive Dementia.

A. Karch, I. Zerr, F. Llorens, 2016, Journal of Alzheimer's disease : JAD.

Rasch progressive Demenzen

I. Zerr, C. Schmidt, K. Stoeck, 2012, Aktuelle Neurologie.

Risk Factors for Disease Progression in Alzheimer's Disease

I. Zerr, A. Shalash, M. Wolff, 2011 .

Investigating the Association of ApoE Genotypes with Blood-Brain Barrier Dysfunction Measured by Cerebrospinal Fluid-Serum Albumin Ratio in a Cohort of Patients with Different Types of Dementia

A. Karch, U. Heinemann, I. Zerr, 2013, PloS one.

CR1 is potentially associated with rate of decline in sporadic Alzheimer’s disease

T. Friede, I. Zerr, K. Lange, 2014, Journal of Clinical Neuroscience.

Alzheimer’s Disease: Genetic Polymorphisms and Rate of Decline

I. Zerr, N. von Ahsen, M. Wolff, 2012, Dementia and Geriatric Cognitive Disorders.

Cerebrospinal Fluid Apolipoprotein E Concentration and Severity of Cognitive Impairment in Patients With Newly Diagnosed Alzheimer’s Disease

I. Zerr, C. Schmidt, Harry Becker, 2014, American journal of Alzheimer's disease and other dementias.

Baseline CSF/Serum-Ratio of Apolipoprotein E and Rate of Differential Decline in Alzheimer's Disease.

T. Friede, I. Zerr, M. Schmitz, 2015, Journal of Alzheimer's disease : JAD.

Pre-progression rates in Alzheimer's disease revisited.

A. Karch, I. Zerr, C. Schmidt, 2013, Journal of Alzheimer's disease : JAD.

Differential Diagnosis of Rapid Progressive Dementia

U. Heinemann, I. Zerr, J. Gawinecka, 2010 .

Plasma Lipocalin 2 in Alzheimer’s disease: potential utility in the differential diagnosis and relationship with other biomarkers

D. Varges, I. Zerr, I. Santana, 2022, Alzheimer's research & therapy.

Increased albumin CSF/serum ratio in dementia with Lewy bodies

D. Varges, I. Zerr, F. Llorens, 2015, Journal of the Neurological Sciences.

Plasma prion protein concentration and progression of Alzheimer disease

T. Friede, I. Zerr, K. Lange, 2014, Prion.

CSF Biomarkers and Neuropsychological Profiles in Patients with Cerebral Small-Vessel Disease

I. Zerr, P. Hermann, C. Romero, 2014, PloS one.

Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non-rapidly progressive Alzheimer’s disease

I. Zerr, D. Wedekind, A. Villar-Piqué, 2023, Alzheimer's Research & Therapy.

On the issue of transmissibility of Alzheimer disease

A. Karch, I. Zerr, C. Korth, 2012, Prion.

Cytokine profiles and the role of cellular prion protein in patients with vascular dementia and vascular encephalopathy

I. Zerr, F. Llorens, M. Schmitz, 2015, Neurobiology of Aging.

Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia

K. Blennow, I. Ferrer, O. Hansson, 2020, Nature Communications.

On the issue of transmissibility of Alzheimer disease

A. Karch, I. Zerr, C. Korth, 2012, Prion.

Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Show Different but Partially Overlapping Profile Compared to Vascular Dementia

I. Zerr, F. Llorens, A. Fischer, 2017, Front. Aging Neurosci..